Nitin Kumar

Nitin Kumar

Auto-generated profile, based on publicly available information

Nitin Kumar

Department of Pharmacy, Saraswathi College of Pharmacy, Anwarpur, Pilkhuwa, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
RMRaghav Mishra
Raghav Mishra
NKNitin Kumar
Nitin Kumar
NSNeetu Sachan
Neetu Sachan
: The field of Free Radical Chemistry has gained considerable interest in the current scenario. The formation of free radicals is attributable to different physiochemical factors, radiation exposure, pathological conditions, environmental contaminants, and as by-products of metabolized drugs. The concentration of free radicals is regulated strongly under normal conditions by physiological antioxidants. Free radicals may cause oxidative damage to proteins, lipids, sugars, and DNA when abundantly produced or when antioxidants are depleted. This imbalance of reduction-oxidation, referred to as oxidative stress, can change the body's physiological conditions and ultimately lead to tissue injury, further contributing to various disease pathologies. A proper balance between free radicals and antioxidants is required for an effective physiological process. The oxidation mechanism is chemically hindered by antioxidants; these are often called free radical scavengers. The application of an external antioxidant source is crucial in addressing the issue of oxidative stress. Plenty of naturally occurring, semi-synthetic, and synthetic antioxidants are used, and the search for an efficient, non-toxic, and safe antioxidant is stepped up over time. As an influential scaffold, thiophene and its derivatives have become a significant source of interest for researchers due to its substantial variety of biological activities. The versatility of thiophene moiety has been identified by an affluent unveiling of its derivatives with anti-inflammatory, antioxidant, anti-cancer, and antimicrobial behaviors. Thiophene activity has been influenced greatly by the nature and orientation of the substitutions. The current study aims at addressing various synthetic compounds with thiophene or condensed thiophene as a fundamental moiety or substituent as radical scavengers.

1 January 2025 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
IMIsha Mishra
Isha Mishra
VSVikram Sharma
Vikram Sharma
NKNitin Kumar
Nitin Kumar
GKGaurav Krishna
Gaurav Krishna
VSVandana Arora Sethi
Vandana Arora Sethi
RMRaghav Mishra
Raghav Mishra
Objectives: Thiophene is one of the most important heterocyclic scaffolds with notable pharmacological properties. Thiophene and its derivatives are of particular interest among sulphurcontaining heterocycles because of their similarities to numerous natural and synthetic compounds with identified potential. The purpose of this study is to extensively analyse the synthetic pathways adopted for synthesising thiophene derivatives and investigate their various biological functions. Methods: A comprehensive review of the existing literature was conducted to collect data pertaining to the methods that are employed for the synthesis of thiophene derivatives. A comprehensive search was carried out through relevant databases, including work published in 2024. A variety of synthesis procedures were identified and arranged, encompassing both traditional approaches like the Gewald reaction and contemporary ones like microwave-assisted synthesis and green synthesis. In addition, a comprehensive compilation of in vitro and in vivo studies was conducted to investigate the biological effects of 50 distinct thiophene derivatives. The primary focus of the studies was on various activities such as anti-cancer, anti-inflammatory, antiprotozoal, antibacterial, antioxidant, and antiviral functions. Results: Diverse methodologies have been employed in the synthesis of thiophene derivatives, encompassing both conventional and modern methods. Furthermore, the biological potential of thiophene derivatives was investigated, demonstrating a broad range of actions. Key structural elements necessary for biological activity were clarified by investigations of the structure-activity relationship. Conclusion: The biological potential and flexible synthesis pathways of thiophene derivatives make them attractive candidates for use in medicinal and pharmaceutical chemistry. Understanding the different synthesis methods and biological actions of thiophene derivatives may assist rational design and create novel treatments for a variety of conditions. The potential for these compounds to be further explored and optimised is considerable for the next drug development initiatives.

23 January 2023 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
JXJayze da Cunha Xavier
Jayze da Cunha Xavier
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
MMMárcia Machado Marinho
Márcia Machado Marinho
MRMatheus Nunes da Rocha
Matheus Nunes da Rocha
ATAlexandre Teixeira
Alexandre Teixeira
RMRaghav Mishra
Raghav Mishra
Background: Studies on natural or synthetic products from chalcones have shown to be very promising due to their peculiar structure that allows different possibilities of reallocation that will define their diverse bioactivities in the creation of new substances. This creation is facilitated by the synthesis of substances in conjunction with the molecular study, which allows a considerable advancement in research, reducing the number of in vitro tests. Objective: This work focuses on the antibacterial activity of chalcones against Staphylococcus aureus, which causes several diseases and is one of the main microorganisms with increasing resistance to conventional drugs. Methods: Articles that studied antibacterial activity, efflux pump, or molecular docking were considered complimentary analyses of chalcones. From these data, molecular docking and ADMET of the first five chalcones were performed with the best activity found. Results: The result of the antimicrobial activity against Staphylococcus aureus was confirmed through in silico study and pharmacokinetic data. Conclusion: The results of the antimicrobial activity of the most active chalcones against Staphylococcus aureus were supported by in silico and pharmacokinetic studies, which not only confirmed their potential to act against resistant strains but also established the future utility of chalcones as lead molecules or prototypes for the synthesis of potent new antimicrobial agents against Staphylococcus aureus.

18 January 2022 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
RMRaghav Mishra
Raghav Mishra
NKNitin Kumar
Nitin Kumar
NSNeetu Sachan
Neetu Sachan
Background: The role of retinoic acid receptor-related orphan receptors in cancer development has raised the interest to develop multi-functional agents. Objective: The main purpose of this work was in silico design and synthesis of potential anticancer candidates with antioxidant effect. Methods: The compounds were designed based on their docking studies with respect to the RORγt receptor. Using the Gewald protocol, a series of new tetrahydrobenzothiophene derivatives was synthesized. The physicochemical and spectroanalytical findings, including FTIR, 1H-NMR, 13C-NMR, and mass spectroscopic techniques, verified the molecular structures of the synthesized derivatives. The anticancer and antioxidant potential of the synthesized compounds was assessed in vitro. The compounds were tested by the National Cancer Institute, USA for anticancer action towards different cell lines representing nine cancerous conditions. The antioxidant activity of compounds was assessed in vitro using the DPPH free radical scavenging method. Results: Docking analysis on RORγt receptors revealed that the test compounds have anticancer potential. Within the binding pocket of the chosen PDB ID (6q7a), RCA3 and RCA5 showed good docking scores in molecular docking studies, validating their capability of being used in rational drug design as lead compounds. Compounds showed diversified ratios of anticancer activity. RCA5 and RCA7 showed excellent antioxidant activity in reference to ascorbic acid with IC50 values of 18.71μg/mL and 20.88μg/mL. Conclusion: Cytotoxicity results very well complemented the docking scores. Compounds RCA3 and RCA5 displayed higher anticancer activity in the subpanels of leukemia, breast cancer, and lung cancer. Compounds RCA5 and RCA7 displayed potent antioxidant action comparable to ascorbic acid, while other compounds presented mild to good antioxidant behavior.

1 February 2025 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
RMRaghav Mishra
Raghav Mishra
JXJayze da Cunha Xavier
Jayze da Cunha Xavier
NKNitin Kumar
Nitin Kumar
GKGaurav Krishna
Gaurav Krishna
PDPrashant Kumar Dhakad
Prashant Kumar Dhakad
SUSucheta
Sucheta
Objectives: Malaria continues to be the primary cause of mortality worldwide, and timely recognition and prompt intervention are crucial in mitigating adverse consequences. This review article aims to examine the effectiveness and structural characteristics of quinoline-based compounds as antimalarial agents. It specifically focuses on their therapeutic effects as well as potential prospects for exploring structure-activity relationship (SAR). In addition, this study aims to identify lead compounds that can efficiently battle multidrug-resistant forms of Plasmodium falciparum and Plasmodium vivax. Methods: A comprehensive review was conducted to evaluate the effectiveness of quinoline-based antimalarial medications in eradicating P. falciparum and P. vivax. The mechanism of action and SAR of these compounds were analyzed Results: Quinoline-based antimalarials demonstrated significant effectiveness in eliminating P. falciparum parasites, particularly in regions severely impacted by malaria, including Africa and Asia. These compounds were found to exhibit tolerance and immune-modulating properties, indicating their potential for more widespread utilization. The investigation identified various new quinoline compounds with improved antimalarial activity, including metal-chloroquine complexes, diaminealkyne chloroquines, and cinnamoylated chloroquine hybrids. This study explored different mechanisms by which these compounds interact with parasites, including their ability to accumulate in the parasite’s acidic food vacuoles and disrupt heme detoxification. The derivatives demonstrated strong efficacy against chloroquine-resistant strains and yielded positive results. Conclusion: Quinoline-based compounds represent a promising avenue for combating malaria due to their demonstrated efficacy against P. falciparum and P. vivax parasites. Further research on their mechanisms of action and SAR could lead to the development of more effective antimalarial medications.

27 June 2026 in International Journal of Pharmacological and Pharmaceutical Innovations (IJPPI)
Verified
Journal Article
Closed access
SVShivam Verma
Shivam Verma
PSPrashant Saraswat
Prashant Saraswat
NKNitin Kumar
Nitin Kumar
Background: Transdermal therapeutic delivery has emerged as a promising substitute for traditional drug administration methods because it offers non-invasive delivery, controlled drug release, reducing presystemic drug metabolism and improving patient acceptance. Despite considerable progress in transdermal technology, the skin continues to pose a significant challenge to drug delivery. The stratum corneum functions as the principal barrier to permeation and limits the successful transport of many therapeutic agents across the skin. Objective: This systematic review aims to critically evaluate recent progress in advanced transdermal delivery platforms, with particular attention to nanocarrierbased systems, stimuli-responsive systems, three-dimensional (3D) printing technologies, and advanced biomaterials, along with their mechanisms, therapeutic potential, and translational challenges. Methods: Literature relevant to transdermal drug delivery was systematically identified using the PRISMA 2020 approach. Electronic databases, including PubMed, Scopus, ScienceDirect, SpringerLink, and Google Scholar, were searched for studies published between January 2020 and December 2024 using predefined keywords related to emerging transdermal delivery technologies. Different Studies were done if they given original research on novel transdermal delivery systems and provided sufficient experimental or clinical evidence. Non-peer-reviewed articles, review papers, studies lacking methodological details, and publications outside the selected time frame were excluded. Results: Advances in nanotechnology have expanded the possibilities of transdermal drug delivery. Lipid-based and polymeric nanoparticle formulations have shown promising outcomes by increasing drug solubility, improving passage through the skin barrier, and sustaining drug release for longer durations. The development of stimulus-sensitive delivery systems has opened new possibilities for targeted therapy. By responding to factors such as pH, temperature, or light, these platforms can provide localized and controlled drug release when required. 3D printing has facilitated the fabrication of personalized transdermal patches with precise dosing and customizable geometries. Biomaterials including hydrogels, microneedles, and biodegradable polymers have further enhanced drug loading capacity and transdermal permeation. Despite these advances, challenges remain regarding long-term safety, regulatory approval, cost-effectiveness, and industrial scalability. Conclusion: Novel transdermal drug delivery systems represent a promising approach for improving therapeutic outcomes for improving the medicinal efficacy of a wide range of medications. The integration of material science, nanotechnology, and biomedical engineering has substantially expanded the capabilities of transdermal therapy. Continued translational and additional clinical investigations are warranted to address current limitations and facilitate the successful commercialization of these advanced advanced delivery technologies for chronic pain therapy, dermatological disorders, metabolic diseases, and other systemic conditions.